Biotech company 10x Genomics (NASDAQ:TXG) will be reporting results this Thursday after market hours. Here’s what investors ...

Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

Key opportunities in the precision oncology market include the rising adoption of personalized therapies, growth in ...

SPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, and ...

According to a filing with the Securities and Exchange Commission dated October 8, 2025, Lancaster Investment Management ...

Q3 2025 Management View Eric Lefkofsky, Co-Founder, CEO, President & Chairman, opened by highlighting that "Q3 was a great quarter all around. Our Genomics volume came in super strong with 33% overall ...

“PacBio’s mission is to enable the promise of genomics to better human health,” said Christian Henry, President and Chief Executive Officer of PacBio. “China’s regulatory approval of Sequel II CNDx ...

First study to evaluate HER2DX in a randomized trial focused exclusively on older individuals (aged 70-80 years). HER2DX independently predicts long-term survival outcomes in patients treated ...

TAPS+ enables simultaneous detection of methylation and genetic variants, unlocking new insights for precision oncology and translational research. Preserves DNA integrity in challenging clinically ...

One in four adults over the age of 25 will have a stroke in a lifetime, according to the Global Stroke Fact Sheet 2025.

MedGenome has announced a strategic investment in Green Cross Genetics Lab to enhance diagnostic services across India, ...